Cost & insurance review · Updated July 2026
How much does Zepbound cost?
Medically reviewed by Editorial Medical Review, MD, NAMS-CMP
Quick answer
$25-$1,086/mo. Zepbound lists at $1,086/month without insurance. Commercial insurance plus the Zepbound Savings Card reduces cost to as low as $25/month. LillyDirect Self Pay single-dose vials offer $349-$599/month cash-pay depending on dose (2.5 mg vial $349; 5-10 mg $499; 15 mg $599).
Price ranges by tier
What each pricing tier includes, sourced from manufacturer pricing pages, Cost Plus Drugs, KFF, LillyDirect, and NovoCare.
Commercial insurance + Savings Card
$25/mo- Prior authorization required (BMI ≥30 or ≥27 + comorbidity)
- Auto-injector pen
- Excludes Medicare/Medicaid
- Capped at $1,463 total savings/year
LillyDirect Self Pay — 2.5 mg vial
$349/mo- Cash-pay direct-to-patient
- Manual-draw vial (not pen)
- No insurance needed
LillyDirect Self Pay — 5-10 mg vial
$499/mo- Vial, not auto-injector pen
- Cash-pay ships to home
LillyDirect Self Pay — 15 mg vial
$599/mo- Vial only
- Highest dose available cash-pay
Retail pharmacy (list price)
$1,086/mo- 4-pen auto-injector pack
- No insurance, no savings card
Factors that affect cost
- Insurance plan formulary status and prior-authorization criteria
- Dose (higher doses cost more via LillyDirect Self Pay)
- Pen vs vial (vials cheaper cash-pay; pens only via insurance)
- Whether the Zepbound Savings Card applies (commercial insurance only)
- Telehealth prescribing fees on top of drug cost
Insurance context
Major commercial insurers (BCBS, Aetna, Cigna, UnitedHealthcare) increasingly cover Zepbound with prior authorization requiring BMI ≥30 or ≥27 + weight-related comorbidity. Medicare Part D excludes anti-obesity drugs statutorily as of 2026 (CMS proposed rule pending). Medicaid coverage varies state-by-state.
Financial help options
- Zepbound Savings Card ↗: Reduces commercially-insured cost to $25/month capped at $1,463/year. Excludes Medicare/Medicaid.
- LillyDirect Self Pay ↗: Cash-pay direct-to-patient vial program. $349-$599/month depending on dose.
- Lilly Cares patient assistance: Free Zepbound for qualifying low-income patients without insurance coverage.
- HSA/FSA accounts: Cover GLP-1 prescriptions and telehealth visits with itemized receipts.
Related brands
Editorial cross-links only — no affiliate CTAs. Follow each link for our full brand review, formulary, and clinician model.
Related questions
Frequently asked questions
- Why does Medicare not cover Zepbound?
- Medicare statutorily excludes most anti-obesity drugs from Part D coverage — a restriction dating to the 2003 Medicare Modernization Act. CMS proposed a rule in 2024 expanding coverage but it remains pending.
- Is compounded tirzepatide still available?
- FDA removed tirzepatide from the shortage list in December 2024, substantially restricting compounded production. Some 503B outsourcing facilities continue for specific clinical scenarios only.
- How does Zepbound cost compare to Wegovy?
- Zepbound lists at $1,086/month; Wegovy at $1,349/month. Both have savings card programs. LillyDirect Self Pay ($349-$599/month) sits below NovoCare Self Pay ($499/month).
- Will Zepbound go generic?
- No — tirzepatide patent protection extends through 2036-2039 in the US. Biosimilar tirzepatide is not possible because tirzepatide is a small-molecule peptide, not a biologic.
Sources
Every pricing figure is sourced from public manufacturer pages, Cost Plus Drugs, KFF, or FDA data. External links open in a new tab.
Related cost questions
ClearHormones publishes editorial pricing research quarterly. Pricing may change without notice — always confirm current terms on the manufacturer or brand pricing page before purchasing.